Viewing Study NCT02110992


Ignite Creation Date: 2025-12-24 @ 3:41 PM
Ignite Modification Date: 2026-04-23 @ 12:50 AM
Study NCT ID: NCT02110992
Status: TERMINATED
Last Update Posted: 2019-11-25
First Post: 2014-04-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
Sponsor: University of Cincinnati
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module